Non-viral Delivery System

Mechanism

Related News

Nanoparticle gene editing restores CFTR function in cystic fibrosis lab model

Apr 25, 2026

Researchers developed a lipid nanoparticle gene-editing approach that inserted a full CFTR gene into airway cells and restored 88% to 100% of normal channel function in a cystic fibrosis lab model.

Nanoparticle Gene Editing Offers New Hope for Cystic Fibrosis Patients

Mar 02, 2026

UCLA scientists developed a lipid nanoparticle-based gene editing system that successfully inserts a full-length healthy CFTR gene into human airway cells, offering potential treatment for cystic fibrosis patients unresponsive to current therapies.